Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Sullivan

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Epilepsia|July 4, 2026
Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectivenessAntonio Gil-Nagel, Kelly G Knupp, Boudewijn Gunning, et al.
The Lancet. Neurology|January 3, 2016
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric Marsh, Daniel Friedman, et al.
Neurology. Genetics|April 12, 2016
Epileptic spasms are a feature of DEPDC5 mTORopathyGemma L Carvill, Douglas E Crompton, Brigid M Regan, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Annals of Neurology|December 26, 2015
Response to treatment in a prospective national infantile spasms cohortKelly G Knupp, Jason Coryell, Katherine C Nickels, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Epilepsy & Behavior : E&B|October 11, 2025
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregiversKelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, et al.
Epilepsia|September 13, 2016
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohortKelly G Knupp, Erin Leister, Jason Coryell, et al.
Epilepsia|March 14, 2025
Variants in ATP6V0C are associated with Dravet-like developmental and epileptic encephalopathyMarlene Rong, Paula T Marques, Quratulain Zulfiqar Ali, et al.
Epilepsia|February 2, 2026
Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history studyIngrid E Scheffer, M Scott Perry, Joseph Sullivan, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Epilepsia|July 4, 2026
Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectivenessAntonio Gil-Nagel, Kelly G Knupp, Boudewijn Gunning, et al.
The Lancet. Neurology|January 3, 2016
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric Marsh, Daniel Friedman, et al.
Neurology. Genetics|April 12, 2016
Epileptic spasms are a feature of DEPDC5 mTORopathyGemma L Carvill, Douglas E Crompton, Brigid M Regan, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Annals of Neurology|December 26, 2015
Response to treatment in a prospective national infantile spasms cohortKelly G Knupp, Jason Coryell, Katherine C Nickels, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Epilepsy & Behavior : E&B|October 11, 2025
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregiversKelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, et al.
Epilepsia|September 13, 2016
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohortKelly G Knupp, Erin Leister, Jason Coryell, et al.
Epilepsia|March 14, 2025
Variants in ATP6V0C are associated with Dravet-like developmental and epileptic encephalopathyMarlene Rong, Paula T Marques, Quratulain Zulfiqar Ali, et al.
Epilepsia|February 2, 2026
Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history studyIngrid E Scheffer, M Scott Perry, Joseph Sullivan, et al.
Pageof 10